Mardi Gomberg‐Maitland

13.7k total citations · 4 hit papers
148 papers, 8.5k citations indexed

About

Mardi Gomberg‐Maitland is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Hepatology. According to data from OpenAlex, Mardi Gomberg‐Maitland has authored 148 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Pulmonary and Respiratory Medicine, 91 papers in Cardiology and Cardiovascular Medicine and 18 papers in Hepatology. Recurrent topics in Mardi Gomberg‐Maitland's work include Pulmonary Hypertension Research and Treatments (130 papers), Cardiovascular Issues in Pregnancy (36 papers) and Cardiovascular Function and Risk Factors (32 papers). Mardi Gomberg‐Maitland is often cited by papers focused on Pulmonary Hypertension Research and Treatments (130 papers), Cardiovascular Issues in Pregnancy (36 papers) and Cardiovascular Function and Risk Factors (32 papers). Mardi Gomberg‐Maitland collaborates with scholars based in United States, United Kingdom and Germany. Mardi Gomberg‐Maitland's co-authors include Stuart Rich, Thenappan Thenappan, Raymond L. Benza, Sanjiv J. Shah, Stephen L. Archer, Robert P. Frantz, Adaani Frost, Aimee J. Foreman, Robyn J. Barst and Michael D. McGoon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Mardi Gomberg‐Maitland

143 papers receiving 8.3k citations

Hit Papers

Predicting Survival in Pu... 2010 2026 2015 2020 2010 2019 2011 2021 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Predicting Survival in Pulmonary Arterial Hypertension
    2010 1.1k citations Raymond L. Benza, Dave P. Miller et al. Circulation profile →
  2. Predicting Survival in Patients With Pulmonary Arterial Hypertension
    2019 390 citations Raymond L. Benza, Mardi Gomberg‐Maitland et al. CHEST Journal profile →
  3. The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension
    2011 389 citations Raymond L. Benza, Mardi Gomberg‐Maitland et al. CHEST Journal profile →
  4. Sotatercept for the Treatment of Pulmonary Arterial Hypertension
    2021 322 citations Marc Humbert, Vallerie V. McLaughlin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mardi Gomberg‐Maitland United States 45 7.1k 5.2k 1.1k 951 811 148 8.5k
Seán Gaine Ireland 38 6.8k 1.0× 4.0k 0.8× 1.2k 1.1× 1.0k 1.1× 665 0.8× 143 8.2k
Laurent Savale France 52 6.6k 0.9× 3.4k 0.6× 1.5k 1.3× 1.3k 1.4× 736 0.9× 251 8.3k
Zhi‐Cheng Jing China 39 8.6k 1.2× 5.8k 1.1× 1.6k 1.4× 1.1k 1.2× 1.0k 1.3× 221 10.6k
Joanna Pepke‐Żaba United Kingdom 44 7.9k 1.1× 4.9k 0.9× 1.6k 1.4× 829 0.9× 593 0.7× 131 9.1k
Ekkehard Grünig Germany 50 9.4k 1.3× 6.7k 1.3× 1.3k 1.1× 789 0.8× 875 1.1× 253 11.5k
Anna R. Hemnes United States 44 5.8k 0.8× 4.1k 0.8× 478 0.4× 896 0.9× 728 0.9× 222 7.2k
Robert P. Frantz United States 49 7.2k 1.0× 6.2k 1.2× 1.1k 1.0× 2.9k 3.1× 1.2k 1.5× 222 10.9k
Florence Parent France 43 6.5k 0.9× 5.2k 1.0× 1.8k 1.6× 1.5k 1.6× 882 1.1× 122 9.6k
Steeve Provencher Canada 53 6.2k 0.9× 3.4k 0.6× 640 0.6× 874 0.9× 617 0.8× 187 8.3k
Tomás Pulido Mexico 28 5.9k 0.8× 4.2k 0.8× 1.2k 1.0× 630 0.7× 785 1.0× 93 6.5k

Countries citing papers authored by Mardi Gomberg‐Maitland

Since Specialization
Citations

This map shows the geographic impact of Mardi Gomberg‐Maitland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mardi Gomberg‐Maitland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mardi Gomberg‐Maitland more than expected).

Fields of papers citing papers by Mardi Gomberg‐Maitland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mardi Gomberg‐Maitland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mardi Gomberg‐Maitland. The network helps show where Mardi Gomberg‐Maitland may publish in the future.

Co-authorship network of co-authors of Mardi Gomberg‐Maitland

This figure shows the co-authorship network connecting the top 25 collaborators of Mardi Gomberg‐Maitland. A scholar is included among the top collaborators of Mardi Gomberg‐Maitland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mardi Gomberg‐Maitland. Mardi Gomberg‐Maitland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montani, David, Vallerie V. McLaughlin, J. Simon R. Gibbs, et al.. (2025). Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR). American Journal of Respiratory and Critical Care Medicine. 211(6). 1028–1037. 3 indexed citations
2.
Cheng, Yan, Adrienne N. Poon, Wen-Chih Wu, et al.. (2024). Heart Failure Among Asian American Subpopulations. JAMA Network Open. 7(9). e2435672–e2435672. 3 indexed citations
3.
Ghofrani, Hossein Ardeschir, Mardi Gomberg‐Maitland, Lan Zhao, & Friedrich Grimminger. (2024). Mechanisms and treatment of pulmonary arterial hypertension. Nature Reviews Cardiology. 22(2). 105–120. 30 indexed citations
4.
Lindley, Kathryn J., C. Noel Bairey Merz, Anita Asgar, et al.. (2021). Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum. Journal of the American College of Cardiology. 77(14). 1778–1798. 40 indexed citations
5.
Ryan, John, Roham T. Zamanian, Ronald J. Oudiz, et al.. (2020). Care of patients with pulmonary arterial hypertension during the coronavirus (COVID‐19) pandemic. Pulmonary Circulation. 10(2). 1–7. 48 indexed citations
6.
Singh, Amita, Akhil Narang, Mardi Gomberg‐Maitland, et al.. (2019). Impact of Severe Pulmonary Arterial Hypertension on the Left Heart and Prognostic Implications. Journal of the American Society of Echocardiography. 32(9). 1128–1137. 25 indexed citations
7.
Simon, Marc A., Mardi Gomberg‐Maitland, Ronald J. Oudiz, et al.. (2019). PATIENTS WITH SEVERE PULMONARY ARTERIAL HYPERTENSION TREATED WITH ABI-009, NAB-SIROLIMUS, AN MTOR INHIBITOR: INTERIM RESULTS FROM A PHASE 1 CLINICAL TRIAL. Journal of the American College of Cardiology. 73(9). 1927–1927. 2 indexed citations
8.
Singh, Amita, Victor Mor‐Avi, Francesco Maffessanti, et al.. (2016). Abstract 19958: Occult Left Atrial Dysfunction in Severe Pulmonary Arterial Hypertension: A Novel Application of Left Atrial Strain. Circulation. 3 indexed citations
9.
Benza, Raymond L., Mardi Gomberg‐Maitland, Teresa DeMarco, et al.. (2015). Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 192(11). 1345–1354. 72 indexed citations
10.
Thenappan, Thenappan, et al.. (2014). β-Blocker Therapy Is Not Associated With Adverse Outcomes in Patients With Pulmonary Arterial Hypertension. Circulation Heart Failure. 7(6). 903–910. 35 indexed citations
11.
Bourge, Robert, Mardi Gomberg‐Maitland, James Tarver, et al.. (2014). Treprostinil Administered Using a Fully Implantable Programmable Intravascular Delivery System: Results of the Delivery for PAH Trial. CHEST Journal. 146(4). 862A–862A. 2 indexed citations
12.
Addetia, Karima, Nicole M. Bhave, Benjamin H. Freed, et al.. (2013). Abstract 18083: Does 6-Minute-Walk Distance Correlate With Right Ventricular Function in Patients With Pulmonary Arterial Hypertension?. Circulation. 128(suppl_22). 1 indexed citations
13.
Gomberg‐Maitland, Mardi, Todd M. Bull, Rajeev Saggar, et al.. (2013). New Trial Designs and Potential Therapies for Pulmonary Artery Hypertension. Journal of the American College of Cardiology. 62(25). D82–D91. 98 indexed citations
14.
Archer, Stephen L., Glenn Marsboom, Gene Kim, et al.. (2010). Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension. Circulation. 121(24). 2661–2671. 319 indexed citations
15.
Benza, Raymond L., Dave P. Miller, Mardi Gomberg‐Maitland, et al.. (2010). Predicting Survival in Pulmonary Arterial Hypertension. Circulation. 122(2). 164–172. 1139 indexed citations breakdown →
16.
Maffessanti, Francesco, Mardi Gomberg‐Maitland, Sonal Chandra, et al.. (2010). Three-dimensional analysis of septal curvature from cardiac magnetic resonance images for the evaluation of severity of pulmonary hypertension. Virtual Community of Pathological Anatomy (University of Castilla La Mancha). 801–804. 1 indexed citations
17.
Thenappan, Thenappan, Sanjiv J. Shah, Stuart Rich, et al.. (2009). Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. European Respiratory Journal. 35(5). 1079–1087. 360 indexed citations
18.
Gomberg‐Maitland, Mardi, Victor F. Tapson, Raymond L. Benza, et al.. (2005). Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 172(12). 1586–1589. 174 indexed citations
19.
Gomberg‐Maitland, Mardi, Sabina A. Murphy, David J. Moliterno, & Christopher P. Cannon. (2005). Are we appropriately triaging patients with unstable angina?. American Heart Journal. 149(4). 613–618. 12 indexed citations
20.
McLaughlin, Vallerie V., Robyn J. Barst, Mardi Gomberg‐Maitland, et al.. (2005). ONE YEAR EXPERIENCE WITH INTRAVENOUS TREPROSTINIL IN PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENTS. CHEST Journal. 128(4). 160S–160S. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seán Gaine Breakdown of academic impact, for papers by Laurent Savale Breakdown of academic impact, for papers by Zhi‐Cheng Jing Breakdown of academic impact, for papers by Joanna Pepke‐Żaba Breakdown of academic impact, for papers by Ekkehard Grünig Breakdown of academic impact, for papers by Anna R. Hemnes Breakdown of academic impact, for papers by Robert P. Frantz Breakdown of academic impact, for papers by Florence Parent Breakdown of academic impact, for papers by Steeve Provencher Breakdown of academic impact, for papers by Tomás Pulido
Rankless by CCL
2026